CARE vs HBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CARE

55.6
AI Score
VS
CARE Wins

HBT

55.2
AI Score

Investment Advisor Scores

CARE

56score
Recommendation
HOLD

HBT

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE HBT Winner
Forward P/E 13.6612 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 68.3% 37.7% CARE
Earnings Growth 253.9% 24.6% CARE
Tradestie Score 55.6/100 55.2/100 CARE
Profit Margin 44.9% 29.2% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: 0.0% · 3M: +35.1% HBT 1M: +9.5% · 3M: +29.1%

Current Technical Phase

CARE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.6% over 20 days), RSI 66

RSI (14): 65.5 · Price: $34.58

HBT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.5% over 20 days), RSI 71

RSI (14): 71.5 · Price: $35.84

Fundamentals Snapshot

Metric CARE HBT
Market Cap
Forward P/E 13.4 11.3
Trailing P/E 6.0 15.5
Revenue (TTM)
Revenue Growth 0.7% 0.4%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.5%
EPS 5.73 2.31
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.